Previous Page  10 / 13 Next Page
Information
Show Menu
Previous Page 10 / 13 Next Page
Page Background

49

Find More Information @

https://obesity.conferenceseries.com

March 2019 Conference Series LLC Ltd

conferenceseries LLC Ltd

19

th

International Conference on

Obesity, Healthcare - Nutrition & Fitness

March 18 - 19, 2019 | New York, USA

Effect of oral ingestion

of low-molecular

collagen peptides

derived from skate

(raja kenojei) skin on

body fat in overweight

adults: a randomized,

double-blind, placebo-

controlled trial

Young Jin Tak

Pusan National University School of

Medicine, South Korea

R

ecent animal studies

found the potential that

collagen peptide derived from

skate skin have anti-obesity

effects through suppression

of fat accumulation and

regulation of lipid metabolism.

However, no studies have yet

been performed in human.

Here, this very first human

study randomized, placebo-

controlled, and double-blinded

was designed to investigate

the efficacy and tolerability of

skate skin collagen peptides

(SCP) for reduction of body fat

in overweight adults. Ninety

healthy volunteers (17 men)

aged 41.2 ± 10.4 years with

mean body mass index of 25.6

± 1.9 kg/m2 were assigned to

the intervention group (IG)

which received 2,000 mg of

SCP per day or to the control

group (CG) given placebo

for 12 weeks and 81 (90%)

participants completed the

study. Changes in body fat

were evaluated using dual

energy X-ray absorptiometry

as a primary efficacy endpoint.

After 12 weeks of trial, the

percentage of body fat and

body fat mass (kg) in IG were

found to be significantly better

than those of subjects in CG

(-1.2% vs. 2.7%, p=0.024 and

-1.2 kg vs. 0.3 kg, p=0.025).

Application of SCP was well

tolerated, and no notable

adverse effect was reported

from both groups. These

results suggest the beneficial

potential of SCP in reduction of

body fat in overweight adults.

03141998@hanmail.net

JOURNAL OF OBESITY &WEIGHT LOSS THERAPY 2019, VOLUME: 4 | DOI: 10.4172/2165-7904-C2-094

ACCEPTED ABSTRACTS